Skip to main
ADPT
ADPT logo

Adaptive Biotechnologies (ADPT)

$0.00

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Buy Adaptive Biotechnologies (ADPT) Stock

About Adaptive Biotechnologies (ADPT)

Adaptive Biotechnologies Corp. engages in the development of an immune medicine platform. Its products and services include immunoSEQ, clonoSEQ, cellular therapy, and vaccines. The company was founded by Chad Robins, Harlan Robins, and Chris Carlson on September 8, 2009 and is headquartered in Seattle, WA.
Market cap$1.74B
Yesterday's volume1.62M
Revenue (TTM)$189.53M
Avg. daily volume2.32M
EBITDA (TTM)-$116.45M
Open$11.25
Price / earnings ratio-11.97x
Yesterday's range$11.2 - $11.81
Debt / equity115.77x
52 week range$3.33 - $12.43
5 year debt / equity51.14x
Beta (LTM)1.65x
Interest coverage-13.24x
Dividend & yield$0.00 (0.00%)
Current ratio2.92x
Ex-dividend date
Next earningsJul 31, 2025
Dividend payable date

Adaptive Biotechnologies Stock Rating

What analysts recommend for ADPT stock, on a scale from 1(buy) to 5(sell).
Buy
Strong Buy 40%
Buy 40%
Hold 13%
Sell 7%
Strong Sell 0%

Frequently Asked Questions (FAQ)

As of Jul 02, 2025, the market cap for ADPT stock is $1.75B

The current P/E ratio for ADPT stock is -11.97

The 52-week high for ADPT stock is $12.43. The current ADPT stock price $undefined is 100.00% below its 52-week high

The 52-week low for ADPT stock is $3.33. The current ADPT stock price $undefined has increased 100.00% from its 52-week low

No, the ADPT stock does not pay dividends to its shareholders

The target price for ADPT stock is $36.20 based on the average of what a group of analyst think ADPT stock could be worth at a future date. This is not a prediction by Public.com

How to buy ADPT stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in ADPT stock

    Navigate to the Explore page. Then, type ADPT into the search bar. When you see ADPT stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased ADPT stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.

Adaptive Biotechnologies Stock Earnings

The value each ADPT share was expected to gain vs. the value that each ADPT share actually gained.

Adaptive Biotechnologies (ADPT) reported Q1 2025 earnings per share (EPS) of -$0.20, beating estimates of -$0.31 by 35.48%. In the same quarter last year, Adaptive Biotechnologies's earnings per share (EPS) was -$0.33. Adaptive Biotechnologies is expected to release next earnings on 07/31/2025, with an earnings per share (EPS) estimate of -$0.24.

Buy Adaptive Biotechnologies (ADPT) Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.